Systematic review of the role of calprotectin in cirrhosis.
Marta FortunyMaria Rosa SarriasMaria TornerIgnacio IborraAriadna ClosAlba ArdèvolRamon BartolíRosa María MorillasEugeni DomènechHelena MasnouPublished in: European journal of clinical investigation (2023)
Calprotectin is emerging as a promising biomarker in ACLD, particularly for the management of bacterial infections and alcohol-related liver disease. Further research with better study designs should help to determine the feasibility of calprotectin measurement in routine clinical practice.